Mineralocorticoid Receptor Antagonists: a Comprehensive Review of Finerenone
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Mineralocorticoid Receptor Antagonists: a Comprehensive Review of Finerenone
Authors
Keywords
-
Journal
Current Cardiology Reports
Volume 22, Issue 11, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-09-10
DOI
10.1007/s11886-020-01399-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Renin-Angiotensin System: Going Beyond the Classical Paradigms
- (2019) Robson A. Souza Santos et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Effects of mineralocorticoid receptor antagonists in proteinuric kidney disease
- (2019) Maria-Eleni Alexandrou et al. JOURNAL OF HYPERTENSION
- The use of a novel non-steroidal mineralocorticoid receptor antagonist finerenone for the treatment of chronic heart failure
- (2018) Hui Pei et al. MEDICINE
- Finerenone Attenuates Endothelial Dysfunction and Albuminuria in a Chronic Kidney Disease Model by a Reduction in Oxidative Stress
- (2018) Raquel González-Blázquez et al. Frontiers in Pharmacology
- Canrenone on cardiovascular mortality in congestive heart failure
- (2018) Giuseppe Derosa et al. PHARMACOLOGICAL RESEARCH
- The novel mineralocorticoid receptor antagonist finerenone attenuates neointima formation after vascular injury
- (2017) Jochen Dutzmann et al. PLoS One
- Efficacy and Safety of Spironolactone in Acute Heart Failure
- (2017) Javed Butler et al. JAMA Cardiology
- A Randomized Controlled Study of Finerenone vs. Eplerenone in Japanese Patients With Worsening Chronic Heart Failure and Diabetes and/or Chronic Kidney Disease
- (2016) Naoki Sato et al. CIRCULATION JOURNAL
- A randomized controlled study of finerenone vs. eplerenone in patients with worsening chronic heart failure and diabetes mellitus and/or chronic kidney disease
- (2016) Gerasimos Filippatos et al. EUROPEAN HEART JOURNAL
- Pharmacokinetics, safety and tolerability of the novel, selective mineralocorticoid receptor antagonist finerenone - results from first-in-man and relative bioavailability studies
- (2016) Silvia Lentini et al. FUNDAMENTAL & CLINICAL PHARMACOLOGY
- Effect of mineralocorticoid receptor antagonists on proteinuria and progression of chronic kidney disease: a systematic review and meta-analysis
- (2016) Gemma Currie et al. BMC Nephrology
- Hypertension: Renin-Angiotensin-Aldosterone System Alterations
- (2015) L. te Riet et al. CIRCULATION RESEARCH
- Nonsteroidal antagonists of the mineralocorticoid receptor
- (2015) Peter Kolkhof et al. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy
- (2015) George L. Bakris et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Spironolactone for Heart Failure with Preserved Ejection Fraction
- (2014) Bertram Pitt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Anti-albuminuric effect of the aldosterone blocker eplerenone in non-diabetic hypertensive patients with albuminuria: a double-blind, randomised, placebo-controlled trial
- (2014) Katsuyuki Ando et al. Lancet Diabetes & Endocrinology
- Safety and tolerability of the novel non-steroidal mineralocorticoid receptor antagonist BAY 94-8862 in patients with chronic heart failure and mild or moderate chronic kidney disease: a randomized, double-blind trial
- (2013) Bertram Pitt et al. EUROPEAN HEART JOURNAL
- The long-term antiproteinuric effect of eplerenone, a selective aldosterone blocker, in patients with non-diabetic chronic kidney disease
- (2011) Nobuo Tsuboi et al. JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
- Regulation of the epithelial sodium channel (ENaC) by membrane trafficking
- (2010) Michael B. Butterworth BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Optimal dose of angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker for renoprotection
- (2010) FAN FAN HOU et al. NEPHROLOGY
- Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms
- (2010) Faiez Zannad et al. NEW ENGLAND JOURNAL OF MEDICINE
- Aldosterone Antagonists for Preventing the Progression of Chronic Kidney Disease: A Systematic Review and Meta-analysis
- (2009) S. D. Navaneethan et al. Clinical Journal of the American Society of Nephrology
- Contraceptive Hormone Use and Cardiovascular Disease
- (2009) Chrisandra L. Shufelt et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Triple Pharmacological Blockade of the Renin-Angiotensin-Aldosterone System in Nondiabetic CKD: An Open-Label Crossover Randomized Controlled Trial
- (2008) Leszek Tylicki et al. AMERICAN JOURNAL OF KIDNEY DISEASES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now